Literature DB >> 15345315

Evaluation of Elispot assays: influence of method and operator on variability of results.

S Janetzki1, S Schaed, N E B Blachere, L Ben-Porat, A N Houghton, K S Panageas.   

Abstract

In this study, a comprehensive comparative analysis of different evaluation methods of Elispot plates was performed. Three investigators using three different evaluation approaches read 50 randomly selected wells at three different time points. The methods were: (1) manual evaluation using a stereomicroscope, (2) automated evaluation using an image analysis reader system with reading parameters established by each investigator, and (3) automated evaluation using a reader system with preset reading parameters using assay-specific controls. We demonstrate that manual evaluation had the highest variability both within the same method and when comparing all methods, followed by automated evaluation with investigator-dependent parameters. The variability was low only when all investigators used the same parameters established using assay-specific controls. This variability was independent of operator or spot number per well. Based on this study, recommendations for standardization and validation procedures of Elispot assay performance and evaluation procedures are presented.

Mesh:

Substances:

Year:  2004        PMID: 15345315     DOI: 10.1016/j.jim.2004.06.008

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  20 in total

1.  Assessment of Imprecision in gamma interferon release assays for the detection of exposure to Mycobacterium tuberculosis.

Authors:  Tamara Tuuminen; Esko Tavast; Riitta Väisänen; Jaakko-Juhani Himberg; Ilkka Seppälä
Journal:  Clin Vaccine Immunol       Date:  2010-02-24

2.  Effect of cryopreservation of peripheral blood mononuclear cells (PBMCs) on the variability of an antigen-specific memory B cell ELISpot.

Authors:  Johannes Trück; Ruth Mitchell; Amber J Thompson; Begonia Morales-Aza; Elizabeth A Clutterbuck; Dominic F Kelly; Adam Finn; Andrew J Pollard
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  Comparison of immunologic assays for detecting immune responses in HIV immunotherapeutic studies: AIDS Clinical Trials Group Trial A5181.

Authors:  Bernard J C Macatangay; Lu Zheng; Charles R Rinaldo; Alan L Landay; Richard B Pollard; Savita Pahwa; Michael M Lederman; R Pat Bucy
Journal:  Clin Vaccine Immunol       Date:  2010-07-14

4.  Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continents.

Authors:  Mark J Boaz; Peter Hayes; Tony Tarragona; Laura Seamons; Andrew Cooper; Josephine Birungi; Paul Kitandwe; Aloysius Semaganda; Pontiano Kaleebu; Gwynneth Stevens; Omu Anzala; Bashir Farah; Simon Ogola; Jackton Indangasi; Patrick Mhlanga; Melanie Van Eeden; Madhuri Thakar; Ashwini Pujari; Shadri Mishra; Nilu Goonetilleke; Stephen Moore; Abdul Mahmoud; Pattabiraman Sathyamoorthy; Jayashri Mahalingam; Paranji R Narayanan; Vadakkuppattu D Ramanathan; Josephine H Cox; Len Dally; Dilbinder K Gill; Jill Gilmour
Journal:  Clin Vaccine Immunol       Date:  2008-12-17

5.  Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice.

Authors:  John Z Metcalfe; Adithya Cattamanchi; Charles E McCulloch; Justin D Lew; Ngan P Ha; Edward A Graviss
Journal:  Am J Respir Crit Care Med       Date:  2012-10-26       Impact factor: 21.405

6.  High reproducibility of the interferon-gamma release assay T-SPOT.TB in serial testing.

Authors:  Thomas Meier; Martin Enders
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-08-08       Impact factor: 3.267

7.  Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients.

Authors:  Yuanxin Xu; Valerie Theobald; Crystal Sung; Kathleen DePalma; Laura Atwater; Keirsten Seiger; Michael A Perricone; Susan M Richards
Journal:  J Transl Med       Date:  2008-10-22       Impact factor: 5.531

8.  Performance of serum-supplemented and serum-free media in IFNgamma Elispot Assays for human T cells.

Authors:  Sylvia Janetzki; L Price; C M Britten; S H van der Burg; J Caterini; J R Currier; G Ferrari; C Gouttefangeas; P Hayes; E Kaempgen; V Lennerz; K Nihlmark; V Souza; A Hoos
Journal:  Cancer Immunol Immunother       Date:  2009-11-06       Impact factor: 6.968

9.  ELISPOT assays and their diagnostic potential in Lyme disease and Lyme neuroborreliosis.

Authors:  N Ettischer-Schmid; R Preyer
Journal:  Clin Exp Immunol       Date:  2020-04-14       Impact factor: 4.330

10.  Defining ELISpot cut-offs from unreplicated test and control wells.

Authors:  Neal Alexander; Annette Fox; Vu Thi Kim Lien; Tao Dong; Laurel Yong-Hwa Lee; Nguyen Le Khanh Hang; Le Quynh Mai; Peter Horby
Journal:  J Immunol Methods       Date:  2013-03-07       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.